Basic Information
RNALocate ID: | RLID:11004371 |
RNA Symbol: | hsa-miR-320d |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-320d |
RNA ID: | miRBase:MIMAT0006764 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23663360 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002800 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11004369 | Exosome | Pooled sera | 27278097 |
RLID:11004370 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11004372 | Exosome | Breast cancer cell lines (MCF-7|MDA-MB-231) | 24468161 |
RLID:11004373 | Exosome | Colon cancer cell line (LIM1863) | 25330373 |
RLID:11004374 | Microvesicle | Plasma | 23077538 |
RLID:11004375 | Microvesicle | Seminal plasma | 23539611 |
RLID-D:11000804 | Microvesicle | Fibroblasts|Mesenchymal stem cells | |
RLID-D:11001744 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-320d | Ovarian clear cell carcinoma | MNDR-E-MI-39497 |
MNDR | hsa-miR-320d | Estrogen-receptor positive breast cancer | MNDR-E-MI-39498 |
MNDR | hsa-miR-320d | Estrogen-receptor negative breast cancer | MNDR-E-MI-39499 |
MNDR | hsa-miR-320d | Progesterone-receptor positive breast cancer | MNDR-E-MI-39500 |
MNDR | hsa-miR-320d | Progesterone-receptor negative breast cancer | MNDR-E-MI-39501 |
MNDR | hsa-miR-320d | Her2-receptor positive breast cancer | MNDR-E-MI-39502 |
MNDR | hsa-miR-320d | Prostate cancer | MNDR-E-MI-39503 |
MNDR | hsa-miR-320d | Gastric cancer | MNDR-E-MI-39504 |
MNDR | hsa-miR-320d | Alzheimer disease | MNDR-E-MI-39505 |
MNDR | hsa-miR-320d | Intracranial aneurysm | MNDR-E-MI-39506 |
MNDR | hsa-miR-320d | Cardiovascular disease | MNDR-E-MI-39507 |
MNDR | hsa-miR-320d | Moyamoya disease | MNDR-E-MI-39508 |
MNDR | hsa-miR-320d | Lung cancer | MNDR-E-MI-39509 |
MNDR | hsa-miR-320d | Parkinson disease | MNDR-E-MI-39510 |
MNDR | hsa-miR-320d | Breast cancer | MNDR-E-MI-39511 |
MNDR | hsa-miR-320d | Pancreatic cancer | MNDR-E-MI-39512 |
MNDR | hsa-miR-320d | Nephroblastoma | MNDR-E-MI-39513 |
MNDR | hsa-miR-320d | Colon cancer | MNDR-E-MI-39514 |
MNDR | hsa-miR-320d | Relapsing-remitting multiple sclerosis | MNDR-E-MI-39515 |
MNDR | hsa-miR-320d | Familial ovarian cancer | MNDR-E-MI-39516 |
MNDR | hsa-miR-320d | Prostate adenocarcinoma | MNDR-E-MI-39517 |
MNDR | hsa-miR-320d | Carcinoma ductal breast | MNDR-E-MI-39518 |
MNDR | hsa-miR-320d | Glioblastoma | MNDR-E-MI-39519 |
MNDR | hsa-mir-320d | Glioma | MNDR-E-MI-39520 |
MNDR | hsa-miR-320d | Chronic obstructive pulmonary disease | MNDR-E-MI-39521 |
MNDR | hsa-miR-320d | Chordoma | MNDR-E-MI-39522 |
MNDR | hsa-miR-320d | Pancreatic ductal adenocarcinoma | MNDR-E-MI-39523 |
MNDR | hsa-miR-320d | Lung squamous cell carcinoma | MNDR-E-MI-39524 |
MNDR | hsa-miR-320d | Non-small cell lung adenocarcinoma | MNDR-E-MI-39525 |
MNDR | hsa-miR-320d | Lung adenocarcinoma | MNDR-E-MI-39526 |
MNDR | hsa-miR-320d | Adrenocortical cancer | MNDR-E-MI-39527 |
MNDR | hsa-miR-320d | Thyroid carcinoma | MNDR-E-MI-39528 |
MNDR | hsa-miR-320d | Pancreatic adenocarcinoma | MNDR-E-MI-39529 |
MNDR | hsa-miR-320d | Myasthenia gravis autoimmune experimental | MNDR-E-MI-39530 |
MNDR | hsa-miR-320d | Kidney renal clear cell carcinoma | MNDR-E-MI-39531 |
MNDR | hsa-miR-320d | Renal clear cell carcinoma | MNDR-E-MI-39532 |
MNDR | hsa-miR-320d | Biliary tract cancer | MNDR-E-MI-39533 |
MNDR | hsa-miR-320d | Head and neck squamous cell carcinoma | MNDR-E-MI-39534 |
MNDR | hsa-miR-320d | Breast invasive carcinoma | MNDR-E-MI-39535 |
MNDR | hsa-miR-320d | Familiar ovarian carcinoma | MNDR-E-MI-39536 |
MNDR | hsa-miR-320d | B-cell lymphoma | MNDR-E-MI-39537 |
MNDR | hsa-miR-320d | Rheumatoid arthritis | MNDR-E-MI-39538 |
MNDR | hsa-miR-320d | Retinoblastoma | MNDR-E-MI-39539 |
MNDR | hsa-miR-320d | Skin cutaneous melanoma | MNDR-E-MI-39540 |
MNDR | hsa-miR-320d | Skin melanoma | MNDR-E-MI-39541 |
MNDR | hsa-miR-320d | Colorectal cancer | MNDR-E-MI-39542 |
MNDR | hsa-miR-320d | Stroke lacunar | MNDR-E-MI-39543 |
MNDR | hsa-miR-320d | Breast cancer her3+ negative | MNDR-E-MI-39544 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABHD13 | Homo sapiens | RR00025355 |
TOP